SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-10-001555
Filing Date
2010-02-26
Accepted
2010-02-26 17:19:59
Documents
13
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2196628z10-k.htm 10-K 1218285
2 EXHIBIT 10.10 a2196628zex-10_10.htm EX-10.10 34562
3 EXHIBIT 10.26 a2196628zex-10_26.htm EX-10.26 4157
4 EXHIBIT 10.52 a2196628zex-10_52.htm EX-10.52 812171
5 EXHIBIT 10.53 a2196628zex-10_53.htm EX-10.53 33378
6 EXHIBIT 10.54 a2196628zex-10_54.htm EX-10.54 93975
7 EXHIBIT 18 a2196628zex-18.htm EX-18 5541
8 EXHIBIT 21.1 a2196628zex-21_1.htm EX-21.1 6131
9 EXHIBIT 23.1 a2196628zex-23_1.htm EX-23.1 4829
10 EXHIBIT 31.1 a2196628zex-31_1.htm EX-31.1 13052
11 EXHIBIT 31.2 a2196628zex-31_2.htm EX-31.2 13421
12 EXHIBIT 32.1 a2196628zex-32_1.htm EX-32.1 6521
13 G413721.JPG g413721.jpg GRAPHIC 65334
  Complete submission text file 0001047469-10-001555.txt   2337619
Mailing Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121
Business Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121 6195522200
AMYLIN PHARMACEUTICALS INC (Filer) CIK: 0000881464 (see all company filings)

IRS No.: 330266089 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-19700 | Film No.: 10640749
SIC: 2834 Pharmaceutical Preparations